NURS 1566 Clinical Form 3: Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Name Trade Name Classification Dose Route Time/frequency

Simvastatin Zocor Lipid-lowering 80mg PO Q HS
agent
Peak Onset Duration Normal dosage range
Unknown Unknown Unknown 5-80 mg/day in the evening

Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
Hypercholesterolemia N/A

Mechanism of action and indications Nursing Implications (what to focus on)

Inhibit an enzyme, 3-hydroxy-3 methylglutarylcoenzyme
A reductase, which is responsible for catalyzing an early
step in the synthesis of cholesterol.
Contraindications/warnings/interactions
Hypersensitivity, acute hypotension, major surgery, trauma,
severe metabolic disturbances, endocrine or electrolyte
disorders.
Common side effects
Dizziness, headache, insomnia, weakness, rhinitis,
bronchitis, Abdominal cramps, constipation, diarrhea,
flatus, heartburn, altered taste, rashes, pruritus.

Interactions with other patient drugs, OTC or herbal
medicines (ask patient specifically)
Unknown
Nursing Process- Assessment
(Pre-administration assessment)
Obtain dietary history, ophthalmic exams are
recommended before and yearly during
therapy.
Lab value alterations caused by medicine
Evaluate serum cholesterol and triglyceride levels before
initiating after 4-6 wk of therapy, and periodically
thereafter. If muscle tenderness develops monitor CPK
levels.
Be sure to teach the patient the following about this
medication
Take medication as directed & do not skip doses, or
double up on missed doses. Avoid drinking more than 1 qt
grapefruit juice during therapy. This medication should be
used in conjunction with diet restrictions, exercise, and
smoking cessation. Photosensitivity (rare).
Assessment Evaluation
Why would you hold or not give this Check after giving
med? Evaluate serum cholesterol
Hypersensitivity reaction, muscle and triglyceride level 4-6
tenderness. weeks after the initiation of
therapy, and periodically
thereafter.